Popular Articles

Small Businesses Wary Of Health Care Legislation
"Rising costs and a weak economy" are leaving small business employees "with higher out-of-pocket health costs," USA Today reports. Those small companies are "exactly what the non-partisan Congressional Budget Office (CBO) had in mind this month when it estimated as many as 15 million people could lose the benefits they currently receive through their jobs under a Democratic proposal to overhaul health care. The estimates were based on an incomplete draft of a bill in the Senate Health, Education, Labor and Pensions Committee, but they touched off a broader debate about who might lose health benefits received through their company. Workers at small firms could be more vulnerable, especially if they pay high premiums." The CBO estimated that "as many as 10 million lower-wage workers would choose to drop their employer-provided insurance because, with proposed government subsidies, it could be cheaper to buy insurance on the open market, especially if they are paying high premiums now." In addition, "Partly because of that exodus, some companies could find it no longer cost effective to offer insurance to the remaining employees, dragging another 10 million people into the open market."
buy viagra
Three Rivers Announces Positive Results From Phase 3 DIRECT Trial Of Once-Daily INFERGEN(R) With Ribavirin In Hepatitis C Virus Treatment Failures
Three Rivers Pharmaceuticals announced positive results of the U.S.-based, randomized Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy (DIRECT) clinical trial authored by Bruce R. Bacon, M.D., of Saint Louis University, and colleagues at 44 centers in the United States. The primary endpoint of increased sustained virological response (SVR), was achieved demonstrating that INFERGEN provides a second chance to those HCV patients failing to respond to standard, first-line therapy of pegylated interferon (PEG-IFN) plus ribavirin (RBV). "The retreatment of PEG-IFN/RBV nonresponders with INFERGEN and RBV is safe and efficacious and can be considered a retreatment strategy for patients failing previous therapy with PEG-IFN/RBV, especially in interferon-sensitive patients with lower baseline fibrosis scores," stated Dr. Bruce Bacon the lead Investigator for the study.
News of the day
New York Times Examines Pilot Program To Fight Drug-Resistant TB In South African Communities
The New York Times examines a Doctors Without Borders pilot program to fight drug-resistant tuberculosis in South Africa that allows patients to stay in their homes rather than be isolated in hospital during treatment. The program, which is supported by the city of Cape Town and the Western Cape Province, aims to "show that such patients can be successfully treated in an impoverished community ò€¦ even while they are still infectious," the New York Times writes.
Cardiovascular

UQ Research Finds A Mother's Mental Health Can Impact On Children

Teenagers whose mothers have mental health impairments are likely to suffer behavioural problems, UQ research has found. Using data from the Mater-University Study of Pregnancy (MUSP), recent PhD graduate Belinda Lloyd studied maternal mental health and its impact on children. The MUSP is a longitudinal study of more than 7000 mothers and their children born at Brisbane"s Mater Hospital between 1981-83. "Children whose mothers experienced mental health problems as their children grew older (during adolescence) had substantially elevated rates of the behavioural and mental health problems measured in the study," Dr Lloyd said. "Also, children whose mothers experienced recurrent mental health problems were significantly more likely to display behavioural and mental health problems. "The impact of maternal mental health problems on children was found to vary, with the timing and recurrence of maternal anxiety and depression being important." Dr Lloyd said while there was a great deal of research and media interest surrounding postnatal depression, there had been less focus on the mental health of mothers over the course of child rearing. Antenatal and postnatal depression alone were found to have no negative impact on children, a finding Dr Lloyd hopes may help reduce the stigma surrounding the conditions. "This finding challenges popular beliefs that antenatal/postnatal anxiety and depression have long-lasting detrimental impacts on child behaviour and mental health," she said. "Self-doubt, feelings of guilt and social stigma could be alleviated knowing impaired maternal mental health is not necessarily going to compromise a child"s mental health and wellbeing into adolescence and beyond." The study found mothers were more likely to experience mental health problems as their children became adolescents, a link which had not previously been adequately explored or documented. "As children grow, there are increasing and more complex demands placed on parents," Dr Lloyd said. "Also, as children grow, parental marital and other intimate relationships are more likely to deteriorate or end, potentially increasing the financial, social, emotional and practical pressures and responsibilities faced by individual parents." Dr Lloyd said the research could inform health professionals of the need to support the mental health needs of mothers as their children grow. "There is capacity for a more holistic approach to child mental health and behaviour that considers the health and wellbeing of parents as a significant factor in child outcomes," she said. "A focus on maternal mental health over the lifecourse instead of isolated periods has the potential to improve the health of women and children, and therefore families and the community." Dr Lloyd"s PhD was completed through UQ"s School of Population Health under the supervision of Professor Jake Najman, Professor Gail Williams and Dr Stuart Kinner. University of Queensland


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):